These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9612453)

  • 1. Homocysteine and vascular disease.
    Wilcken DE
    Med J Aust; 1998 May; 168(9):431-2. PubMed ID: 9612453
    [No Abstract]   [Full Text] [Related]  

  • 2. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.
    Kok FJ
    Bibl Nutr Dieta; 2001; (55):189-91. PubMed ID: 11125576
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale for risk reduction of cardiovascular disease using homocysteine concentration in blood and plasma as biomarker: support by clinical data.
    Pietrzik K
    Bibl Nutr Dieta; 2001; (55):34-41. PubMed ID: 11125582
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of various regimens of vitamin B6 and folic acid on mild hyperhomocysteinaemia in vascular patients.
    Franken DG; Boers GH; Blom HJ; Trijbels JM
    J Inherit Metab Dis; 1994; 17(1):159-62. PubMed ID: 8051932
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
    Tamura T; Bergman SM; Morgan SL
    Int J Artif Organs; 1998 Feb; 21(2):72-4. PubMed ID: 9569127
    [No Abstract]   [Full Text] [Related]  

  • 7. [Homocysteine lowering with folic acid and B vitamins in vascular disease].
    Liakishev AA
    Kardiologiia; 2006; 46(5):70. PubMed ID: 16858361
    [No Abstract]   [Full Text] [Related]  

  • 8. Homocysteine and fracture prevention.
    van Meurs JB; Uitterlinden AG
    JAMA; 2005 Mar; 293(9):1121-2. PubMed ID: 15741537
    [No Abstract]   [Full Text] [Related]  

  • 9. Homocysteine, vitamins and sex.
    Hockly E; Brown MJ
    Eur Heart J; 1999 Sep; 20(17):1222-3. PubMed ID: 10454973
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine reduction by B-vitamin supplementation increases t-PA and PAI-1 levels in patients with venous thromboembolism.
    Rodrigues CA; Morelli VM; DA Silveira RC; D'Almeida V; Lourenço DM
    J Thromb Haemost; 2007 Jan; 5(1):195-8. PubMed ID: 17059414
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhomocysteinemia and the response to vitamin supplementation.
    Ubbink JB; van der Merwe A; Vermaak WJ; Delport R
    Clin Investig; 1993 Dec; 71(12):993-8. PubMed ID: 8124058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
    Lonn E
    JAMA; 2008 May; 299(17):2086-7. PubMed ID: 18460669
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
    J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes, greens, and homocysteine.
    Meleady RA; Mulcahy DA; Graham IM
    Heart; 1996 Aug; 76(2):103-4. PubMed ID: 8795467
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial.
    Woodside JV; Yarnell JW; McMaster D; Young IS; Harmon DL; McCrum EE; Patterson CC; Gey KF; Whitehead AS; Evans A
    Am J Clin Nutr; 1998 May; 67(5):858-66. PubMed ID: 9583842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A statement of homocyst(e)ine and cardiovascular disease.
    Heart and Stroke Foundation of Canada
    Can J Cardiol; 2001 Jul; 17(7):763-6. PubMed ID: 11515496
    [No Abstract]   [Full Text] [Related]  

  • 18. Homocysteine: update on a new risk factor.
    Ballal RS; Jacobsen DW; Robinson K
    Cleve Clin J Med; 1997; 64(10):543-9. PubMed ID: 9385741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does lowering plasma homocysteine reduce vascular disease risk?
    Miller JW
    Nutr Rev; 2001 Jul; 59(7):242-4. PubMed ID: 11475450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and neurologic disease.
    Diaz-Arrastia R
    Arch Neurol; 2000 Oct; 57(10):1422-7. PubMed ID: 11030793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.